Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Pancreatic Enzymes is a mixture of several digestive enzymes produced by the exocrine cells of the pancreas. Pancreatin is usually obtained from the pancreas of pigs or cows. The pancreas is an organ in animals and people that makes chemicals - amylase, lipase, and protease - that are needed for proper digestion. This mixture is used to treat conditions in which pancreatic secretions are deficient, such as surgical pancreatectomy, pancreatitis and cystic fibrosis.
The largest proportion of Pancreatin is used in Pharma Industry, and the consumption proportion is approximately 64% in 2019.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 35 % in 2019. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of over 23%.
Market competition is intense. Shenzhen Hepalink, Nordmark, Sichuan Deebio, ALI, etc. are the leaders of the industry, dominating nearly 30% of the global market. The competitors in tier 2 are Chongqing Aoli, Sichuan Biosyn, Geyuan Tianrun and American Laboratories, Inc. (ALI).
The global Pancreatic Enzymes market was valued at US$ 113.2 million in 2019 and is expected to reach US$ 252.5 million by the end of 2026, growing at a CAGR of 12.2% during 2021-2026.
This report focuses on Pancreatic Enzymes volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pancreatic Enzymes market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Pancreatic Enzymes Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Pancreatin Powder
Pancreatin Pellets
Segment by Application
Food Processing
Pharma Industry
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Shenzhen Hepalink
Nordmark
Sichuan Deebio
Sichuan Biosyn
Chongqing Aoli
American Laboratories, Inc. (ALI)
Geyuan Tianrun
Spectrum Chemicals
The largest proportion of Pancreatin is used in Pharma Industry, and the consumption proportion is approximately 64% in 2019.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 35 % in 2019. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of over 23%.
Market competition is intense. Shenzhen Hepalink, Nordmark, Sichuan Deebio, ALI, etc. are the leaders of the industry, dominating nearly 30% of the global market. The competitors in tier 2 are Chongqing Aoli, Sichuan Biosyn, Geyuan Tianrun and American Laboratories, Inc. (ALI).
The global Pancreatic Enzymes market was valued at US$ 113.2 million in 2019 and is expected to reach US$ 252.5 million by the end of 2026, growing at a CAGR of 12.2% during 2021-2026.
This report focuses on Pancreatic Enzymes volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pancreatic Enzymes market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Pancreatic Enzymes Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Pancreatin Powder
Pancreatin Pellets
Segment by Application
Food Processing
Pharma Industry
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Shenzhen Hepalink
Nordmark
Sichuan Deebio
Sichuan Biosyn
Chongqing Aoli
American Laboratories, Inc. (ALI)
Geyuan Tianrun
Spectrum Chemicals
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
